Amarex logo

  • Home
  • News and Resources
  • Resources
  • Use of a Patch Containing Heat-Labile Toxin From Escherichia Coli Against Travellers’ Diarrhoea: A Phase II, Randomised, Double-Blind, Placebo-Controlled Field Trial

Use of a Patch Containing Heat-Labile Toxin From Escherichia Coli Against Travellers’ Diarrhoea: A Phase II, Randomised, Double-Blind, Placebo-Controlled Field Trial

Enterotoxigenic Escherichia coli (ETEC) is a major cause of travellers' diarrhoea. We investigated the rate of diarrhoea attacks, safety, and feasibility of a vaccine containing heat-labile enterotoxin (LT) from ETEC delivered to the skin by patch in travellers to Mexico and Guatemala.

Contact Us

Book a meeting or send us a message to talk to one of our experts.